International Flavors & Fragrances (NYSE:IFF – Get Rating) and Cyclo Therapeutics (NASDAQ:CYTH – Get Rating) are both consumer staples companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, institutional ownership, risk, dividends and earnings.
Volatility & Risk
International Flavors & Fragrances has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500. Comparatively, Cyclo Therapeutics has a beta of -0.76, suggesting that its stock price is 176% less volatile than the S&P 500.
90.7% of International Flavors & Fragrances shares are held by institutional investors. Comparatively, 7.1% of Cyclo Therapeutics shares are held by institutional investors. 0.2% of International Flavors & Fragrances shares are held by company insiders. Comparatively, 12.3% of Cyclo Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
This table compares International Flavors & Fragrances and Cyclo Therapeutics’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|International Flavors & Fragrances||2.32%||6.37%||3.39%|
This is a summary of current recommendations for International Flavors & Fragrances and Cyclo Therapeutics, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|International Flavors & Fragrances||1||2||7||0||2.60|
International Flavors & Fragrances currently has a consensus target price of $156.92, suggesting a potential upside of 31.32%. Cyclo Therapeutics has a consensus target price of $16.00, suggesting a potential upside of 640.74%. Given Cyclo Therapeutics’ stronger consensus rating and higher probable upside, analysts clearly believe Cyclo Therapeutics is more favorable than International Flavors & Fragrances.
Valuation & Earnings
This table compares International Flavors & Fragrances and Cyclo Therapeutics’ top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|International Flavors & Fragrances||$11.66 billion||2.61||$270.00 million||$1.01||118.31|
|Cyclo Therapeutics||$1.59 million||8.77||-$14.29 million||($2.26)||-0.96|
International Flavors & Fragrances has higher revenue and earnings than Cyclo Therapeutics. Cyclo Therapeutics is trading at a lower price-to-earnings ratio than International Flavors & Fragrances, indicating that it is currently the more affordable of the two stocks.
International Flavors & Fragrances beats Cyclo Therapeutics on 10 of the 14 factors compared between the two stocks.
International Flavors & Fragrances Company Profile (Get Rating)
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. It operates through Nourish, Scent, Health & Biosciences, and Pharma Solutions segments. The Nourish segment offers natural and plant-based specialty food ingredients, such as flavor compounds, and savory solutions and inclusions. It also provides natural food protection ingredients consist of natural antioxidants and anti-microbials as well as beverages, sweets , and dairy products. The Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that could be combined with other materials to create fragrance and consumer compounds; and cosmetic active ingredients consisting of active and functional ingredients, botanicals, and delivery systems to support its customers' cosmetic and personal care product lines. The Health & Biosciences segment develops and produces enzymes, food cultures, probiotics, and specialty ingredients. The Pharma Solutions segment produces and sells cellulosics and seaweed-based pharma excipients. The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products. International Flavors & Fragrances Inc. was founded in 1833 and is headquartered in New York, New York.
Cyclo Therapeutics Company Profile (Get Rating)
Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida.
Receive News & Ratings for International Flavors & Fragrances Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Flavors & Fragrances and related companies with MarketBeat.com's FREE daily email newsletter.